Can Biomarkers Improve Ability of NPI in Risk Prediction? A Decision Tree Model Analysis
Author(s):
Baneshi Mr , Warner P. , Anderson N. , Tovey S. , Edwards J. , Bartlett Jms
Abstract:
Background
The Nottingham Prognostic Index (NPI) is widely-used in the UK for risk stratification of breast cancer patients. This paper aims to evaluate the ability of this index to detect patients with sufficiently low risk of recurrence that they could be spared harsh treatments، and to construct an enhanced prognostic rule that integrates biomarkers with clinical variables to achieve better risk stratification. Methods
We undertook review of published studies of outcomes in risk groups derived by applying NPI، and report estimated event-free rates extracted from papers found. Then we analysed biological and clinical variables for 401 ER+ patients، to develop a Tree-based Survival Model (TSM)، for risk prediction، and estimated event-free rates by resulting risk-groups، Kaplan-Meier (K-M) curves corresponding to TSM and NPI were plotted. Results
We concluded that NPI does not distinguish low risk patients with a sufficiently high event-free rate to make it likely clinicians would decide treatments with potential harmful side effects can be avoided in that group. On the other hand، in the decision tree constructed، utilising 3 biomarkers، nodal status and tumour size، the 4 risk groups were clearly diverged in terms of event-free rates. Conclusion
There is considerable potential for improved prognostic modelling by incorporation of biological variables into risk prediction. Whilst low risk patients identified by our TSM model could potentially avoid systemic treatment، higher risk patients might require additional treatment، including chemotherapy or other adjuvant treatment options. However، the decision tree model needs to be validated in a larger clinical trial cohort.Language:
English
Published:
International Journal of Cancer Management, Volume:3 Issue: 2, Spring 2010
Page:
62
magiran.com/p735688
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!